A detailed history of Rafferty Asset Management, LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 32,368 shares of FULC stock, worth $140,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,368
Holding current value
$140,800
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.18 - $9.74 $102,930 - $315,264
32,368 New
32,368 $115,000
Q1 2022

May 13, 2022

SELL
$9.96 - $23.65 $129,191 - $306,764
-12,971 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$14.0 - $28.44 $181,594 - $368,895
12,971 New
12,971 $229,000

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $226M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.